FORE Biotherapeutics
About
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.
Technology stack
detected 2026-06-18Est. monthly stack spend~$420/mo
Email
Microsoft 365
Stack
jQuery
WordPress
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does FORE Biotherapeutics do?
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer. (formerly NovellusDX.)
How much funding has FORE Biotherapeutics raised?
FORE Biotherapeutics has raised a total of $148M in funding. The most recent round on record is Series D.
When was FORE Biotherapeutics founded?
FORE Biotherapeutics was founded in 2011.
What industry does FORE Biotherapeutics operate in?
FORE Biotherapeutics operates in Healthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology.
How many employees does FORE Biotherapeutics have?
FORE Biotherapeutics has approximately 55 people on record.